Immunophenotypic Pattern of De Novo Malignancy After Liver Transplantation.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Historique:
received: 31 01 2018
revised: 12 04 2018
accepted: 27 04 2018
pubmed: 19 1 2019
medline: 26 3 2019
entrez: 19 1 2019
Statut: ppublish

Résumé

Long-term survival after liver transplantation is affected by de novo neoplasia. The incidence of this type of malignancy is increased in the setting of immunosuppressive therapy. The aim of this study was to characterize the immunologic pattern of liver transplant recipients with de novo malignancies. Fifty-one liver recipients were studied, 19 of whom had a history of de novo neoplasia. Immunophenotypic patterns among patients with/without tumors were compared. The subpopulations of CD4

Identifiants

pubmed: 30655139
pii: S0041-1345(18)30882-0
doi: 10.1016/j.transproceed.2018.04.090
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-79

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

J P González (JP)

School of Medicine, University of Navarra, Pamplona, Navarra, Spain.

A Zabaleta (A)

Flow Cytometry Core, Centro de Investigación Médica Aplicada, Pamplona, Navarra, Spain.

P Sangro (P)

Department of Internal Medicine, Clínica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain.

J E Basualdo (JE)

Liver Unit, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra and Centro de Investigación Biomédica de enfermedades hepáticas y Digestivas, Pamplona, Navarra, Spain.

L Burgos (L)

Flow Cytometry Core, Centro de Investigación Médica Aplicada, Pamplona, Navarra, Spain.

B Paiva (B)

Flow Cytometry Core, Centro de Investigación Médica Aplicada, Pamplona, Navarra, Spain.

J I Herrero (JI)

Department of Internal Medicine, Clínica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain; Liver Unit, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra and Centro de Investigación Biomédica de enfermedades hepáticas y Digestivas, Pamplona, Navarra, Spain. Electronic address: iherrero@unav.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH